EAGLE PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2012 to 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Eagle Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2022.
Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was $10.3M, a 368% increase year-over-year.
Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was $41M, a 29% decline year-over-year.
Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $81M, a 2824% increase from 2021.
Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $2.77M, a 91.6% decline from 2020.
Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was $33M, a 51.1% increase from 2019.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$81M	+$78.2M	+2824%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-23
2021	$2.77M	-$30.2M	-91.6%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-23
2020	$33M	+$11.1M	+51.1%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-23
2019	$21.8M	-$14.8M	-40.4%	Jan 1, 2019	Dec 31, 2019	10-K	2022-03-08
2018	$36.6M	-$37.4M	-50.5%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-05
2017	$74M	+$20.6M	+38.7%	Jan 1, 2017	Dec 31, 2017	10-K	2020-03-02
2016	$53.4M	+$50.8M	+1984%	Jan 1, 2016	Dec 31, 2016	10-K	2019-02-28
2015	$2.56M	+$21.3M		Jan 1, 2015	Dec 31, 2015	10-K	2018-02-26
2014	-$18.8M	-$10.3M	-122%	Oct 1, 2013	Sep 30, 2014	10-K	2017-03-15
2013	-$8.46M	+$11.4M	+57.4%	Oct 1, 2012	Sep 30, 2013	10-K	2016-02-29
2012	-$19.8M			Oct 1, 2011	Sep 30, 2012	10-K	2014-12-22

Showing 1 to 11 of 11 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.